Home » Topics » BioWorld Science

BioWorld Science
RSS

Neovacs reports phase IIb results for IFN-alpha kinoid in moderate to severe lupus

July 3, 2018

Merck & Co. presents FFA1 receptor agonists

July 3, 2018

FDA grants priority review to sBLA for Keytruda with chemotherapy in first-line metastatic NSCLC

July 3, 2018

NovaTarg divulges new AMPK activators for diabetes

July 3, 2018

Entyvio approved in Japan for ulcerative colitis

July 3, 2018

Glactone Pharma Development patents STAT3 inhibitors

July 3, 2018

Dafclir receives approval in Japan

July 3, 2018

Topline data reported from phase IIa trial of IRL-752 in Parkinson's disease dementia

July 3, 2018

TRIGR Therapeutics and ABL Bio collaborate in immuno-oncology

July 3, 2018

Advicenne reports preliminary phase III extension study results for ADV-7103

July 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...